Overview
RAAPID is a healthtech company founded in 2022 and based in New York, United States. The company develops an AI-powered clinical risk-adjustment platform that employs a neuro-symbolic approach to connect diagnoses with encounter-based evidence.
Clinical risk adjustment is a process used in healthcare to account for differences in patient populations when comparing outcomes or costs across providers. RAAPID's platform addresses the need for more accurate and evidence-based methods of linking patient diagnoses to clinical encounters, which has applications in healthcare quality measurement, payment models, and clinical decision support.
Activities and products
RAAPID's primary offering is the RAAPID AI Platform, which uses artificial intelligence to perform clinical risk adjustment. The platform applies a neuro-symbolic methodology, combining neural network approaches with symbolic reasoning to establish connections between diagnoses and the clinical evidence associated with specific patient encounters. This technical approach aims to improve the accuracy and interpretability of risk-adjustment calculations in healthcare settings.
Stage and funding
RAAPID is at the seed stage of development. The company is bootstrapped, and no public information is available regarding external funding or investor backing at this time.
Photograph: Vitaly Gariev / Unsplash
Company details
- Legal name
- RAAPID
- Website
- www.raapid.com
- Headquarters
- New York, United States
- Founded
- 2022
- Sector
- Healthtech
- Funding stage
- Seed